Key result
Higher medium-term SBP variability linked to ~12% greater cardiovascular mortality risk.
Why the study?
Assessing the impact of blood-pressure variability on health outcomes is challenged by multiple independent or interactive timescales of variability and large stochastic uncertainty from modest numbers of observations.
Does short-term and medium-term blood pressure variability predict all-cause and cardiovascular mortality?
Observational (n=14,654)
Yes
Does short-term and medium-term blood pressure variability predict all-cause and cardiovascular mortality?
Effect estimate: RR 1.12
Medium-term, but not short-term, blood pressure variability is a significant independent predictor of long-term cardiovascular and all-cause mortality, persisting even after controlling for the Framingham risk score.
Medium-term SBP variability may refine CV mortality risk stratification beyond Framingham score; hypothesis-generating for interventional trials.
In considering the impact of blood-pressure variability on health outcomes, two methodological challenges arise: The presence of multiple timescales of variability that may act independently and interactively, and the fairly large stochastic uncertainty that is inevitable in estimates of individual variability based on modest numbers of observations. Here we present an application of Bayesian hierarchical modeling to the problem of estimating the effect of blood pressure (BP) variability on all-cause and cardiovascular mortality with two timescales – short-term variation among multiple measures at one visit, and medium-term variation between the measures at two visits several months apart. We use data from the Third National Health and Nutrition Examination Survey linked with up to 27 years of mortality follow-up. We find that medium-term systolic BP variability had a very significant predictive value for CV and all-cause mortality, around one-third as large as the well-established impact of mean systolic BP. Medium-term diastolic variability had an additional, though smaller, predictive effect. Short-term variability, on the other hand, had little or no measurable predictive value. The medium-term variability effect persisted when controlling for Framingham risk score.
No takes yet. Share an insight, caveat, or question.
Steinsaltz et al. (2023) conducted an observational in Blood pressure variability (n=14,654). Medium-term blood pressure variability (inter-visit difference) vs. Mean blood pressure / Low variability was evaluated on Cardiovascular mortality (RR 1.12). Medium-term systolic blood pressure variability significantly predicted cardiovascular mortality, with a 4.7-point increase in intervisit difference corresponding to a 12% increase in mortality risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: